GlaxoSmithKline (GSK) has launched a new multi-channel campaign for its brand Panadol, focusing on the acute pain recovery journey.
Pharmacists and their teams can support those suffering from heartburn and acid reflux with advice and products, Nexium Control manufacturer GSK has said.
Ear care brand Cl-ear offers a "significant" sales opportunity for pharmacies, especially when people go on holiday, manufacturer EM Pharma has said.
Thea has launched a reusable warm compress, the Blepha EyeBag, which can help treat a range of eye conditions, it has announced.
GSK Consumer Healthcare has appointed Bas Vorsteveld as vice president and general manager for Great Britain and Ireland.
Brancaster Pharma’s Bramox 10mg tablets are now on the Drug Tariff, offering potential compliance and budget-saving opportunities, the manufacturer has announced.
PharmaDoctor has launched two COVID-19 test kits for travellers who are required to take them.
Johnson & Johnson UK and Ireland has added Aveeno Soothing Bath Soak to its Aveeno range to help relieve dry, itchy and irritable skin while bathing.
Just 8% of pharmacy team members would recommend proton pump inhibitors (PPIs) – such as Nexium Control – as a first-line treatment for frequent heartburn, a GlaxoSmithKline (GSK) survey has revealed.
Tony Maleedy’s Juniper Scalp Therapy shampoo can treat seborrheic dermatitis, scalp psoriasis, and other scalp conditions, according to the manufacturer.
GlaxoSmithKline (GSK) has decided to change the names of three Voltarol products to make it easier for pharmacists and pharmacy staff to recommend and locate them in the pharmacy.
Pharmacists can recommend OTC treatments and guidance on managing pain relief to help patients take a proactive approach in looking after their health this Self Care Week, GlaxoSmithKline (GSK) has said.
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.